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1. lntroduetion 
Bacteriophage MS2 is one of the group of closely 
related small icosahedral RNA phages. The coat protein 
shell is composed of 180 subunits [l] and one A-pro- 
tein molecule [2,3] . The A-protein is in some way re- 
quired for proper assembly since defective particles are 
formed during the growth of A-cistron amber mutants 
in non-permissive cells [4,5]. These defective parti- 
cles contain originally an intact RNA-molecule, but 
which protrudes through the capsid and is accessible to 
nucleases present in the solvent [6,7]. Furthermore 
infective phage is only obtained in reconstitution ex- 
periments when A-protein is present [8] . 
It is not clear, however, whether the A-protein is 
still required once a complete and perfect virion has 
been formed. We found that in high salt the A-protein 
is preferentially lost from the viral particles. Some 
hints for this effect have previously been published 
in the literature [9] . The A-protein-less particles re- 
main physically intact, unlike “defective particles”, 
but are not infective. We conclude that A-protein is 
not only essential for proper assembly, but also for 
subsequent infection. 
2. Materials and methods 
Growth and purification of the virus was essential- 
ly as previously described [ 10,l l] . l4 C-labeled phage 
was grown in TPG medium [ 121 containing 0.01% 
(w/v) Casamino acids. Immediately after infection 
(m.o.i. = 5), a [14C] protein hydrolysate (Schwarz 
Bio Research) was added to 4 @i/ml. The last step in 
North-Holland Pu blishing Company - Amsterdam 
in the purification consisted of a centrifugation on a 
linear 1 O-30% glycerol gradient in 5 X 10e3 M Tris 
buffer, 10m3 MgClz and 10e4 M EDTA, adjusted to 
pH 7.4 with HCl, instead of banding in a CsCl-gra- 
dient. The gradients were centrifuged for 2.5 hr at 
40,000 rpm in the SW41 rotor at 2”. 
For density gradient centrifugation, the virus sus- 
pension was added to 1.65 g CsCl and the volume 
was adjusted to 3 ml with buffer ( 10e3 M Tris, 10m3 M 
MgClz and 10e4 M EDTA, pH 7.4). Centrifugation was 
carried out for 30 hr at 2” in the SW65 rotor at 
37,500 rpm. Fractions were collected by piercing the 
bottom of the tube. 
Total phage protein was analyzed on 10% polyacryl- 
amide gels containing sodium dodecyl sulfate [ 11,131. 
The gels were prerun with 0.1 M phosphate buffer, 
pH 7.2 containing thioglycolic acid to remove the per- 
sulfate. Prior to electrophoresis the proteins were hea- 
ted in 0.01 M phosphate buffer, pH 7.2 in the pres- 
ence of 2% SDS and 0.14 M /3-mercaptoethanol. 
3. Results and discussion 
In order to calculate changes in the number of A- 
protein molecules per virus particle we used phage 
uniformly labeled with a[ l4 C] protein hydrolysate. 
When the purified phage preparation was subjected to 
a CsCl-gradient centrifugation, a decrease in specific 
infectivity (being the ratio of infectivity to radioactiv- 
ity) was observed (table 1). The top fractions of the 
gradient (fig. 1A) were collected and a second centrifu- 
gation was performed (fig. 1B). The two peak fractions 
(indicated by the arrows) had a 2-fold difference in spe- 
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Table 1 
November 197 2 
Correlation between infectivity of MS2 phage and A-protein content. 
(Specific infectivity)a (%)b 
moles A-proteinc 
virus particle (%)b 
Purified phage 
After first CsCl gradient centrifugationd 
After second CsCl gradient dentrifuga- 
tion (fig. l,B) : 
Fraction no. 10 
Fraction no. 9 
5.8 X lo5 100 0.96 100 
2.8 X 10’ 48.9 0.44 45.8 
7.4 x lo4 12.7 0.13 13.5 
3.87 X lo4 6.7 0.08 8.3 
aRatio of pfu over cpm. bThe value for the original preparation of purified phage is taken as 100. CUniform labeling of both pro- 






Fig. 1. CsCl density gradient centrifugation of purified MS2 
virions uniformally labeled with a [ I4 C] -protein hydrolysate. 
A) 1 ml of the phage preparation was mixed with a CsCl so- 
lution and centrifuged as described in Materials and methods. 
B) The top fractions indicated in fig. 1A were collected and 
1 ml was subjected to a second CsCl-gradient centrifutation. 
Radioactivity c&e*); infectivity (X--X--X). 
cific infectivity. 
All samples with different specific infectivity were 
concentrated by centrifugation for 2.5 hr at 50,000 
rpm and 2’ for further analysis. The pellet was resus- 
pended, heated in detergent-buffer, and the proteins 
were separated by electrophoresis on polyacrylamide 
gels (fig. 2.). More than 96% of the radioactivity was 
found in the two peak fractions, thP main component 
being the coat protein while the minor band with a 
mobility of 0.4 relative to that of tie coat protein 
corresponds to the A-protein. It must be noted that 
1.6 to 2.5% of the total radioactivity remained at the 
interphase of the gels. This was due to some insoluble 
material which could be removed by prior centrifu- 
gation of the sample before loading. When this pellet 
was solubilized with 8 M urea and analyzed again by 
electrophoresis, the same ratio of coat protein to A- 
protein was found as in the original sample. 
The A-protein being approx. 3 times as large as the 
coat protein, the number of A-protein molecules per 
virion could be estimated from the radioactivity 
found in the peak fractions. The results of these experi- 
ments are summarised in table 1. 
Virions which have not been centrifuged through 
a CsCl gradient contain - within the limitations of 
the method used - one A-protein molecule per par- 
ticle. By centrifugation in CsCl, this A-protein is gra- 
dually lost, and there is a very satisfactory correlation 
between loss of A-protein and drop in specific infec- 
tivity. It should be noted that the A-protein-less 
particles, formed in this manner, are different from 
the defective particles formed by A-amber mutants 
in non-permissive cells. The former remain structural- 
ly nearly intact and still sediment at approx. 80 S, 
while the latter sediment at 69 S [7] because of a 
higher frictional coefficient due to protruding RNA- 
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Fig. 2. Analysis of the phage proteins by electrophoresis on acrylamide gel. Proteins from virus samples with different specific 
infectivity were electrophoresed for 5 hr on 10% acrylamide gels at 7 mA/tube as previously described. The gels were then sliced 
and assayed for radioactivity. The anode is to the right. (A) Original preparation. (B) Fractions indicated in fig. 1A ( purified 
virion after first CsCl-gradient centrifugation). C) Fraction number 10 and D) fraction number 0 of fig. 1B (purified particles after a 
second CsCl-gradient centrifugation). The specific infectivity of the virions is indicated in table 1. 
segments. The fact that A-protein can be dissociated 
from the virion in high salt suggests that ionic bonds 
are involved in its interactions, either with the capsid 
proteins or with the RNA. Direct binding with the RNA 
is in agreement with the recent finding that upon in- 
fection the A-protein penetrates into the host cyto- 
plasm together with the RNA-molecule [ 14, 151. 
We conclude that A-protein is necessary, not only 
for proper assembly during maturation, but also for 
one or more subsequent processes, e.g. adsorption, 
penetration or early eclipse phase. 
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